Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07574606
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle FlapFuture University in EgyptRecruitingNot Applicable
NCT07574606Recruiting
Not Applicable
Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla...Future University in Egyp...
NCT07576595
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansLouisiana State University Health Sciences Center in New OrleansRecruitingNot Applicable
NCT07576595Recruiting
Not Applicable
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Amo...Louisiana State Universit...
NCT07575438
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk AdultsDiabetes CanadaNot Yet RecruitingPhase 2
NCT07575438Not Yet Recruiting
Phase 2
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk...Diabetes Canada
NCT07575412
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07575412Not Yet Recruiting
Phase 2
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSThe First Affiliated Hosp...
NCT07574944
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Providers on Resuscitation Management and Kangaroo Mother Care: Simulation-based Training for Asyphxia in Babies Trial (STAR-Baby Trial)Development and Research Service International NepalNot Yet RecruitingNot Applicable
NCT07574944Not Yet Recruiting
Not Applicable
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Pro...Development and Research...
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
NCT07575906
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.PfizerNot Yet RecruitingPhase 1
NCT07575906Not Yet Recruiting
Phase 1
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is T...Pfizer
NCT07576062
Efficacy of Cognitive Functional Therapy in Individuals With Chronic Low Back Pain After Spinal SurgeryCentro Universitário Augusto MottaNot Yet RecruitingNot Applicable
NCT07576062Not Yet Recruiting
Not Applicable
Efficacy of Cognitive Functional Therapy in Individuals With Chronic Low Back Pa...Centro Universitário Augu...
NCT07574554
Fixation of Mandibular Angle Fracture Using 3D Titanium Miniplate Versus Standard Two Plate FixationCairo UniversityActive Not RecruitingNot Applicable
NCT07574554Active Not Recruiting
Not Applicable
Fixation of Mandibular Angle Fracture Using 3D Titanium Miniplate Versus Standar...Cairo University
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07575607
Reflexology vs Progressive Muscle Relaxation for Fatigue in Hemodialysis PatientsCairo UniversityNot Yet RecruitingNot Applicable
NCT07575607Not Yet Recruiting
Not Applicable
Reflexology vs Progressive Muscle Relaxation for Fatigue in Hemodialysis Patient...Cairo University
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
NCT07576647
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)McMaster UniversityNot Yet RecruitingNot Applicable
NCT07576647Not Yet Recruiting
Not Applicable
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision...McMaster University
NCT07576660
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled TrialSoutheast University, ChinaNot Yet RecruitingPhase 3
NCT07576660Not Yet Recruiting
Phase 3
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrom...Southeast University, Chi...
NCT07576413
Effects of Standing Desks and Intermittent Walking on Cognitive FatigueClarkson UniversityCompletedNot Applicable
NCT07576413Completed
Not Applicable
Effects of Standing Desks and Intermittent Walking on Cognitive FatigueClarkson University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07575555
The Effect of Lipedema on Knee OsteoarthritisIzmir Democracy UniversityNot Yet Recruiting
NCT07575555Not Yet Recruiting
—
The Effect of Lipedema on Knee OsteoarthritisIzmir Democracy Universit...
NCT07576998
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE TrialMicrovention-Terumo, Inc.Not Yet RecruitingNot Applicable
NCT07576998Not Yet Recruiting
Not Applicable
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic S...Microvention-Terumo, Inc.
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Active, not recruiting2 (10%)
Completed1 (5%)
not_applicable11 (55%)
Phase 23 (15%)
Phase 13 (15%)
Not Specified2 (10%)
Phase 31 (5%)